Levodopa‐Carbidopa Intestinal Gel Improves Dyskinesia in Parkinson's Disease: Post Hoc Analysis from the <scp>COSMOS</scp> Study

LCIG led to reductions in dyskinesia severity, regardless of baseline dyskinesia burden. Dyskinesia duration improved in patients with high dyskinesia burden but not in those with low dyskinesia burden.

Authors

Institutions

Publication Details

Journal
Movement Disorders Clinical Practice
Published
2025-08-15
DOI
https://doi.org/10.1002/mdc3.70222
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Levodopa‐Carbidopa Intestinal Gel Improves Dyskinesia in Parkinson's Disease: Post Hoc Analysis from the COSMOS Study

Cleanthe Spanaki, Tanya Gurevich, Mihaela Simu, Per Svenningsson et al.
Movement Disorders Clinical Practice
Parkinson's Disease Mechanisms and Treatments
article

Levodopa‐Carbidopa Intestinal Gel Improves Dyskinesia in Parkinson's Disease: Post Hoc Analysis from the COSMOS Study

Cleanthe Spanaki, Tanya Gurevich, Mihaela Simu, Per Svenningsson, Abdallah Saad, Lars Bergmann, Robert Jech, Alfonso A. Fasano, Lydia Vela, Juan Carlos Parra, Norbert Kovács, József Attila Szász
article en

Abstract

LCIG led to reductions in dyskinesia severity, regardless of baseline dyskinesia burden. Dyskinesia duration improved in patients with high dyskinesia burden but not in those with low dyskinesia burden.

Movement Disorders Clinical PracticeVol. 13(1)
Tel Aviv University (IL), Charles University (CZ), Toronto Western Hospital (CA), Tel Aviv Sourasky Medical Center (IL), Karolinska Institutet (SE), AbbVie (United States) (US), Universitatea de Medicină, Farmacie, Științe și Tehnologie „George Emil Palade” din Târgu Mureș (RO), Victor Babeș University of Medicine and Pharmacy Timișoara (RO), Hospital Universitario Fundación Alcorcón (ES), Krembil Foundation (CA), University Hospital of Heraklion (GR), General University Hospital in Prague (CZ), Krembil Research Institute, University of Pecs (HU)
Pfizer, GlaxoSmithKline, Sanofi, Teva Pharmaceutical Industries, Boston Scientific Corporation, European Commission, Kommunfullmäktige, Stockholms Stad, University of Toronto, Knut och Alice Wallenbergs Stiftelse, EVER Neuro Pharma, Servier, H. Lundbeck A/S, Ipsen, AOP Orphan, Allergan
Good health and well-being
Openalex Percentile: Top 70%
Parkinson's Disease Mechanisms and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.